Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SORCS3 antisense RNA 1 (SORCS3-AS1) is an intragenic, non-protein-coding RNA gene transcribed antisense to the SORCS3 protein-coding locus on chromosome 10. It is classified as an antisense lncRNA with strong evidence for non-coding status (PhyloCSF, CPAT, Bazzini, PRIDE)[1]. There is no published literature or direct functional characterization of SORCS3-AS1. Alternative transcript names and accessions exist across major databases (NCBI, Ensembl, NONCODE), but its molecular function, disease relevance, and biological mechanisms remain unexplored. SORCS3-AS1 is distinct from SORCS3, which encodes a receptor protein involved in neuronal signaling and disease[3][7][9]. Summary of distinctions: - SORCS3-AS1 is an antisense lncRNA, not a protein, receptor, or enzyme[1][6][8]. - No disease, drug, or biomarker association is reported for SORCS3-AS1[1][2][6][8]. - Most available literature and disease associations concern SORCS3, not SORCS3-AS1[3][7][9]. All major databases (NCBI, Ensembl, LNCipedia, BioGPS, Thermo Fisher) corroborate the existence and sequence information of SORCS3-AS1, but do not provide functional or therapeutic relevance[1][2][5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SORCS3 antisense RNA 1 (SORCS3-AS1).